Alerts will be sent to your verified email
Verify EmailSHELTER
Shelter Pharma
|
Concord Drugs
|
Lasa Supergenerics
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
15.08 % | 3.38 % | -8.32 % |
5yr average Equity Multiplier
|
1.38 | 1.86 | 1.44 |
5yr Average Asset Turnover Ratio
|
2.02 | 0.9 | 0.77 |
5yr Avg Net Profit Margin
|
7.29 % | 1.88 % | -8.22 % |
Price to Book
|
0.0 | 1.52 | 0.59 |
P/E
|
7.03 | 121.87 | 0.0 |
5yr Avg Cash Conversion Cycle
|
151.86 Days | 260.53 Days | 11.27 Days |
Inventory Days
|
65.6 Days | 138.17 Days | 46.83 Days |
Days Receivable
|
77.72 Days | 144.77 Days | 10.61 Days |
Days Payable
|
5.04 Days | 77.93 Days | 83.41 Days |
5yr Average Interest Coverage Ratio
|
71.95 | 1.8 | -18.91 |
5yr Avg ROCE
|
21.3 % | 8.9 % | 1.03 % |
5yr Avg Operating Profit Margin
|
11.0 % | 9.09 % | 9.99 % |
5 yr average Debt to Equity
|
0.04 | 0.55 | 0.2 |
5yr CAGR Net Profit
|
138.7 % | -21.63 % | n/a |
5yr Average Return on Assets
|
11.22 % | 1.77 % | -5.59 % |
Shareholdings
|
|||
Promoter Holding
|
52.32 % | 54.39 % | 53.65 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 20.66 % |
Change in Promoter Holding (3 Yrs)
|
-4.57 % | 5.39 % | 9.87 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Shelter Pharma
|
Concord Drugs
|
Lasa Supergenerics
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|